Josh Gottheimer sold Amneal Pharmaceuticals, Inc. Class A Common Stock (NASDAQ: AMRX)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 1 trade in Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) since 2019, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Amneal Pharmaceuticals, Inc. Class A Common Stock (NASDAQ: AMRX) on May 24, 2019. Since that trade, AMRX is up +123.16% against the S&P 500 up +191.16%, an outperformance of -68.00%.
Data updated
Josh Gottheimer's AMRX trades vs the price
AMRX is up +123.16% since Josh Gottheimer sold on May 24, 2019, versus +191.16% for the S&P 500.
Performance since this trade
All Josh Gottheimer AMRX trades
Josh Gottheimer & AMRX trading FAQ
Is it legal for Josh Gottheimer to trade Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell AMRX?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) on May 24, 2019, according to public STOCK Act filings.
How has AMRX performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold AMRX on May 24, 2019, the stock is up +123.16%, versus +191.16% for the S&P 500 over the same period, an outperformance of -68.00%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional AMRX trades?
Quantellect tracks every disclosed congressional trade in Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) on the Amneal Pharmaceuticals, Inc. Class A Common Stock congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's AMRX tradesAll congressional filings for Amneal Pharmaceuticals, Inc. Class A Common StockJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.